The Anderson Analysis

Facing a 'going concern' warning, Pulmatrix abandons its drug pipeline for a reverse merger, betting its survival on the high-risk field of longevity science.

Radian has bet its future on a massive strategic pivot. New CEO Mike Weinbach brings a mortgage tech playbook to a complex global insurance game. Will it work?

As LatiNation Media turns 25, its strategy shifts to vertical video, rap battles, and financial insights to capture the next generation of Latino viewers.

Textio's new AI platform, Lavalier, promises to measure 'culture fit' with data, not gut feelings. But can an algorithm truly solve hiring's bias problem?

In a sector known for complex deals, Vertical Data's simple, no-warrants capital raise signals a disciplined strategy. But can it scale in the AI arms race?

OneDigital's new AI platform promises to shift benefits from a cost-cutting exercise to a strategic investment. But does it work? A deep dive.

RTI International's latest award is more than a trophy. It's a data-backed case study in building a resilient culture that drives talent retention and business success.

As Firehouse Subs opens its 1,500th store, we analyze its unique model blending franchisee success, a $115M mission, and RBI's strategic backing.

Marti Technologies is rapidly expanding its ride-hailing empire across Türkiye. But behind impressive growth numbers lies a complex web of operational risks.

Recur Software's acquisition of FLAGS isn't just a deal; it's a strategic move to transform manufacturing quality from a reactive chore to a predictive science.

The building materials giant overcame a brutal Q1, but a closer look reveals a complex strategy of restructuring, asset sales, and operational pivots.

A 22% surge in women seeking financial help isn't just a number. It's a signal from an economic crucible, revealing a proactive shift from survival to strategy.

A national cottage cheese shortage has grocers scrambling. Gay Lea Foods' $200M facility expansion is a massive bet, but is it a resilient strategy or a reactive play?

The fintech pioneer's sustained growth isn't just an award—it's a masterclass in strategy, adaptation, and capitalizing on regulatory tailwinds.

Landing on the Inc. 5000 list four years running is impressive, but SavvyMoney's real achievement lies in building the B2B engine powering modern banking.

The biotech has gone all-in on its lead drug, bel-sar, cutting 20% of staff and shelving a promising bladder cancer program to secure its financial future.

The Inc. 5000 list reveals more than fast growth. Cohere Health's success shows health plans are abandoning fragmented AI for integrated clinical intelligence.

As Johnson & Johnson prepares for a key investor conference, its strategy hinges on a potent mix of new drugs, robotic surgery, and a leaner focus.

Healthcare Management Administrators appoints Diane Zalewski as CEO. Her Evernorth success signals a focus on innovation amid rising costs for self-funded employers.

As children return to school, many Arizona adults are starting their own educational journeys, pivoting to high-demand trades in months, not years.